Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Argus Health
Federal Trade Commission
Covington
Chubb
Accenture
Fish and Richardson
Chinese Patent Office
Healthtrust

Generated: September 23, 2018

DrugPatentWatch Database Preview

Piperazine citrate - Generic Drug Details

« Back to Dashboard

Summary for piperazine citrate
US Patents:0
Tradenames:5
Applicants:8
NDAs:8
Drug Master File Entries: 18
Bulk Api Vendors: 39
Patent Applications: 131
DailyMed Link:piperazine citrate at DailyMed
Synonyms for piperazine citrate
2-hydroxypropane-1,2,3-tricarboxylic acid,piperazine,pentahydrate
2-hydroxypropane-1,2,3-tricarboxylic acid; piperazine
3C6H8O7.3C4H10N2.H2O
642.66 (anhydrous)
AC1L3FX5
AC1Q5SNX
ACMC-20ahp5
AK-47855
AKOS015920444
Antepar
antepar hydrate
Anthecole
Antoban
ANW-73863
Ascarex Syrup
AX8148136
BR-47855
Bryrel
C12H30N6??C12H16O14??xH2O
C6H8O7.C4H10N2
CHEMBL1200842
Citric acid sesquipiperazine salt hydrate 250mg
CITRIC ACID; PIPERAZINE
CTK0H7247
DAK 63
Exelmin
Exopin
GS-3869
HE057177
HE342185
Helmezine
Helmizin
Jsp002598
KB-259286
KS-00000GXD
LS-111398
LS-174889
MolPort-023-221-326
MolPort-039-145-053
Multifuge citrate
Nemadital
NSC-203336
NSC-86779
NSC203336
NSC86779
Oxucide
Oxyzin (syrup)
Oxyzine
Oxyzine (syrup)
Parazine
Parazine citrate
Pin-Tega
Pinozan
Piperasol
Piperazine 2-hydroxypropane-1,2,3-tricarboxylate
Piperazine citrate (3:2) hydrate
Piperazine Citrate (anhydrous)
Piperazine Citrate Telra
Piperazine Citrate USP
Piperazine compound with citric acid
Piperazine, 2-hydroxy-1,2,3-propanetricarboxylate (3:2), hydrate
Piperazine, citrate (3:2)
Piperazine,2,3-propanetricarboxylate (3:2)
Pipizan
Pipizan Citrate Syrup
Rhomex
RT-001192
S-7217
SC-22711
SCHEMBL125278
Ta-Verm
Vermago
Vermizine (elixir)
WLN: T6M DMTJ & 3 & 622 & QV1XQVQ1VQ & 2 & 621

US Patents and Regulatory Information for piperazine citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us BRYREL piperazine citrate SYRUP;ORAL 017796-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lannett PIPERAZINE CITRATE piperazine citrate SYRUP;ORAL 080963-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold PIPERAZINE CITRATE piperazine citrate SYRUP;ORAL 080671-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline ANTEPAR piperazine citrate TABLET;ORAL 009102-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Argus Health
Federal Trade Commission
Covington
Chubb
Accenture
Fish and Richardson
Chinese Patent Office
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.